As of April 16, 2025, Rapport Therapeutics (RAPP) has a market cap of $0.35 billion USD. According to our data, Rapport Therapeutics is ranked No.6339 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.35 B |
-46.00%
|
Dec 31, 2024 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.06 B |
-0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Biohaven Pharmaceutical
BHVN
|
$1.89 B |
0.000 M
|
![]() USA
|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.50 B |
-0.000 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$9.51 B |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.76 B |
-0.000 M
|
![]() USA
|
![]() Vanda Pharmaceuticals
VNDA
|
$0.25 B |
-0.000 M
|
![]() USA
|
![]() Minerva Neurosciences
NERV
|
$10.32 M |
0.000 M
|
![]() USA
|
![]() Otsuka Holdings
4578.T
|
$25.08 B |
-0.204 B
|
![]() Japan
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
Market Cap | = | RAPP Stock Price | * | RAPP Shares Outstanding |
= | $9.60 | * | 36.50 M | |
= | $0.35 B |